TOTELLE Coated tablet Ref.[49525] Active ingredients: Estradiol Trimegestone

Source: Health Products Regulatory Authority (IE)  Revision Year: 2016  Publisher: Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24

Product name and form

Totelle 1 mg/ 0.125 mg coated tablets.

Pharmaceutical Form

Coated tablet.

Blue, round, biconvex, coated tablet printed with “1/0.125”.

Qualitative and quantitative composition

Each coated tablet contains 1.03 mg estradiol hemihydrate corresponding to 1.00 mg estradiol and 0.125 mg trimegestone.

Excipients with known effects: Lactose monohydrate and sucrose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Estradiol

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.

Trimegestone

Trimegestone is a 19-norpregnane progestagen, with an in vitro affinity for the progesterone receptor approximately 6 times that of progesterone. As oestrogens promote the growth of the endometrium, unopposed oestrogens increase the risk of endometrial hyperplasia and cancer. The addition of a progestagen reduces, but does not eliminate the oestrogen-induced risk of endometrial hyperplasia in non-hysterectomised women.

List of Excipients

Core:

Lactose monohydrate
Macrogol 8000
Magnesium stearate
Talc

Coating:

Anhydrous calcium sulfate
Carnauba wax
Indigo carmine aluminium lake (E132)
Glycerol mono-oleates
Macrogol 20000
Microcrystalline cellulose
Pharmaceutical glaze (shellac)
Povidone
Printing ink (Black iron oxide (E172), Shellac and Propylene glycol)
Stearic acid
Sucrose
Titanium dioxide (E171)

Pack sizes and marketing

28 tablets in blister (PVC/PE/ACLAR/Aluminium).

The package sizes are 1 × 28 tablets and 3 × 28 tablets. Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24

Marketing authorization dates and numbers

PA0822/073/001

Date of first authorisation: 18 December 2003
Date of last renewal: 22 November 2009

Drugs

Drug Countries
TOTELLE Brazil

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.